122 related articles for article (PubMed ID: 1525410)
1. Antitumor effect and tumor level of 5-fluoro-2'-deoxyuridylate following oral administration of tetradecyl 2'-deoxy-5-fluoro-5'-uridylate.
Nakajima Y; Iigo M; Hoshi A
Anticancer Drugs; 1992 Jun; 3(3):289-92. PubMed ID: 1525410
[TBL] [Abstract][Full Text] [Related]
2. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin.
Iigo M; Nishikata K; Hoshi A
Jpn J Cancer Res; 1992 Apr; 83(4):392-6. PubMed ID: 1387127
[TBL] [Abstract][Full Text] [Related]
3. Sequential methotrexate/5-FU: FdUMP formation and TS inhibition in a transplantable rodent colon adenocarcinoma.
Berne MH; Gustavsson BG; Almersjö O; Spears PC; Frösing R
Cancer Chemother Pharmacol; 1986; 16(3):237-42. PubMed ID: 3698165
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of alkylesters of 5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP) against murine lymphoma L5178Y resistant to 5-fluoro-2'-deoxyuridine.
Kanzawa F; Matsushima Y; Ishihara J; Hoshi A; Ohba T; Watanabe K
J Pharmacobiodyn; 1986 Aug; 9(8):688-93. PubMed ID: 2946859
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of 2,2'-anhydro-5-ethyluridine, a uridine phosphorylase inhibitor, on the antitumor activity of 5-fluorouridine and 5-fluoro-2'-deoxyuridine.
Iigo M; Nishikata K; Nakajima Y; Szinai I; Veres Z; Szabolcs A; De Clercq E
Biochem Pharmacol; 1990 Apr; 39(7):1247-53. PubMed ID: 2138895
[TBL] [Abstract][Full Text] [Related]
6. Increased cytotoxicity and decreased in vivo toxicity of FdUMP[10] relative to 5-FU.
Liu J; Skradis A; Kolar C; Kolath J; Anderson J; Lawson T; Talmadge J; Gmeiner WH
Nucleosides Nucleotides; 1999 Aug; 18(8):1789-802. PubMed ID: 10478484
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of FdUMP[10] in treatment of HT-29 human colon cancer xenografts.
Liu C; Willingham M; Liu J; Gmeiner WH
Int J Oncol; 2002 Aug; 21(2):303-8. PubMed ID: 12118325
[TBL] [Abstract][Full Text] [Related]
8. [Phase I clinical study of TT-62. Research group of TT-62].
Taguchi T; Furue H; Niitani H; Ohta K; Tsukagoshi S; Wakui A; Hasegawa K; Nakao I; Ohashi Y; Tominaga T
Gan To Kagaku Ryoho; 1993 Feb; 20(2):241-6. PubMed ID: 8434962
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor evaluation of bis[(pivaloyloxy)methyl] 2'-deoxy-5-fluorouridine 5'-monophosphate (FdUMP): a strategy to introduce nucleotides into cells.
Farquhar D; Khan S; Srivastva DN; Saunders PP
J Med Chem; 1994 Nov; 37(23):3902-9. PubMed ID: 7966151
[TBL] [Abstract][Full Text] [Related]
10. Concurrent allopurinol and 5-fluorouracil: 5-fluoro-2'-deoxyuridylate formation and thymidylate synthase inhibition in rat colon carcinoma and in regenerating rat liver.
Berne M; Gustavsson B; Almersjö O; Spears CP; Waldenström J
Cancer Chemother Pharmacol; 1987; 20(3):193-7. PubMed ID: 3677297
[TBL] [Abstract][Full Text] [Related]
11. In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.
Spears CP; Shahinian AH; Moran RG; Heidelberger C; Corbett TH
Cancer Res; 1982 Feb; 42(2):450-6. PubMed ID: 6173112
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of action of FdUMP[10]: metabolite activation and thymidylate synthase inhibition.
Bijnsdorp IV; Comijn EM; Padron JM; Gmeiner WH; Peters GJ
Oncol Rep; 2007 Jul; 18(1):287-91. PubMed ID: 17549381
[TBL] [Abstract][Full Text] [Related]
13. 5'-[4-(Pivaloyloxy)-1,3,2-dioxaphosphorinan-2-yl]-2'-deoxy-5-fluorouridine: a membrane-permeating prodrug of 5-fluoro-2'-deoxyuridylic acid (FdUMP).
Farquhar D; Chen R; Khan S
J Med Chem; 1995 Feb; 38(3):488-95. PubMed ID: 7853342
[TBL] [Abstract][Full Text] [Related]
14. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.
Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH
Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504
[TBL] [Abstract][Full Text] [Related]
15. Comparative physiologic dispositions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.
Chadwick M; Chang C
Cancer Treat Rep; 1976 Jul; 60(7):845-55. PubMed ID: 137772
[TBL] [Abstract][Full Text] [Related]
16. [Development of fluorinated pyrimidines in Japan].
Taguchi T
Gan To Kagaku Ryoho; 1993 Jan; 20(1):10-8. PubMed ID: 8422172
[TBL] [Abstract][Full Text] [Related]
17. Competitive binding radioassay for the determination of 5-fluorodeoxyuridine and 5-fluorodeoxyuridine-5'-monophosphate levels in plasma and tumor tissue.
Miyata S; Mikami H; Tai M; Hori T; Fujita H
Jpn J Cancer Res; 1991 Jun; 82(6):742-6. PubMed ID: 1830300
[TBL] [Abstract][Full Text] [Related]
18. Relationship between 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomas.
Houghton JA; Weiss KD; Williams LG; Torrance PM; Houghton PJ
Biochem Pharmacol; 1986 Apr; 35(8):1351-8. PubMed ID: 3008760
[TBL] [Abstract][Full Text] [Related]
19. Tumor size and origin determine the antitumor activity of cisplatin or 5-fluorouracil and its modulation by leucovorin in murine colon carcinomas.
Van Laar JA; Rustum YM; Van der Wilt CL; Smid K; Kuiper CM; Pinedo HM; Peters GJ
Cancer Chemother Pharmacol; 1996; 39(1-2):79-89. PubMed ID: 8995503
[TBL] [Abstract][Full Text] [Related]
20. On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived mice.
Houghton JA; Houghton PJ
Cancer; 1980 Mar; 45(5 Suppl):1159-67. PubMed ID: 6444543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
